New combo therapy for rare skin lymphoma shows early promise
NCT ID NCT06235281
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 27 times
Summary
This early-phase study tests whether combining phototherapy (light treatment) with the drug mogamulizumab can help control early-stage mycosis fungoides, a rare type of skin lymphoma. About 20 adults with stage IA-IIA disease will receive both treatments together. The main goal is to see how many patients' skin lesions improve or disappear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOSIS FUNGOIDES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.